Role of dialysable solutes in the mediation of uremic encephalopathy in the rat. This study addresses mechanisms of the clinical, encephalopathic uremic illness and its suppression by dialysis. Renoprival rats were treated with peritoneal dialysis (8 exchanges per day, 30 mm dwell), or untreated (attrition group), and their EEG's were automatically sampled overnight and subjected to power spectrum analysis as an index of encephalopathy. As in man the background rhythm of the quantified EEG (Q.EEG) in the attrition group slowed with time as extracellular fluid composition became increasingly abnormal; these changes were normalized by therapeutic dialysis (TD) using standard, commercial diálysate. However, Q.EEG slowing was only partially normalized by solute-specific dialysis using 'mock uremic dialysate" (M-UD), prepared from laboratory chemicals to equal plasma concentrations in preterminal uremic rats of urea, creatinine, potassium, phosphorus, calcium, magnesium, bicarbonate, sodium, and chloride. When only phosphate was added to TD, the Q.EEG slowed to the same level achieved after M-UD. We conclude that uremic encephalopathy in this model is produced by an unknown neurotoxin and augmented by one or more of the M-UD solutes, phosphate being a likely candidate. To localize the encephalopathic effect, regional brain glucose uptake was estimated in 20 discrete brain areas. Significance of reduced uptake in three areas is discussed.
dialysis. The extent to which any of these moieties contribute to uremic encephalopathy is, however, unknown.
The pathogenesis of uremie encephalopathy has been explored by a number of authors in terms of the electrical and metabolic indices of brain function. In the rat, Van den Noort et al [17] found that creatinine, phosphate, ATP and glucose content were increased but that there were corresponding decreases in creatinine, AMP, ADP and lactate. Total brain adenine nucleotide content was normal to low. The work of Mahoney, Sarnaeki and Arieff [181 on the ui-ernie dog would suggest that energy charge in the ui-ernie brain is unchanged while substrate utilization is reduced.
The present investigation sought to examine the encephalopathic effect of uremia in a nephrectomized rat model amenable to chronic conscious ambulatory Q.EEG recording and peritoneal dialysis (PD). Our purpose was to investigate the correlation, if any, between encephalopathic changes in the EEG and the abnormal concentration of commonly measured ECF solutes that occur in renal failure and are modified by dialysis. In addition, because glucose uptake and metabolism is critical for brain function we postulated that the observed neurobehavioral deficits and their amelioration by dialysis should be reflected in differences in quantitative regional cerebral glucose uptake (rCGlu). With this model, the "dialysable neurotoxin" hypothesis was tested insofar as it relates to the combined influences of urea, creatinine, calcium, phosphorus and potassium, while sodium and chloride and presumably bicarbonate remained essentially unchanged. The method has previously been successfully used to maintain conscious ambulatory renoprival animals for up to 13.5 days and to determine the relationship between degree of uremia and degree of Q.EEG slowing in this species [14, 191 . It was hypothesized that dialysate formulated to contain "uremic" levels of these solutes-so as to prevent their dialytic removal from the renoprival rat's extracellular fluid (ECF)-would maintain orexacerbate the encephalopathic syndrome if one or more of them contributed to the neurotoxic effect. Finally, the model was employed in a single, initial example of single-solute-specific dialysis in which Q.EEG responses were recorded when dialysate levels of phosphate only were elevated to "uremic" levels.
Methods

Animals
There were fifty-five male Sprague-Dawley rats (Sasco Laboratories, 250 g) used in these studies. Animal housing and experimental facilities employed identical temperature and humidity control with 12 hour light-dark rhythm. Animals were acclimated for one week prior to surgical implantation of chronic extradural silver ball EEG electrodes. Electrode implantation was performed using the method of Lipman and Harshman [20] . Briefly, monopolar electrodes were chronically emplaced through burr holes in the skull bilaterally over frontal and occipitoparietal cortices, a fifth, reference, electrode being embedded in the bone of the nasion. The electrodes were connected to a plug permanently mounted to the animal's skull.
Fourteen days were permitted to elapse to ensure proper healing. Quantitative electroencephalographic (Q.EEG) measurements were then made, sampling for 100 seconds every two hours from groups of ten rats at a time for one week, using an automated procedure we have previously described [21, 22] . Slowing of the dominant frequencies due to encephalopathy was therefore indexed in these Q.EEG measurements by deriving the theta:alpha ratio (TAR) which is the ratio of powers (p.V2) in theta and alpha bands (Power 3 to 7 Hz/Power 7 to 13 Hz; Fig. 1 ). Eight 100-second Q.EEG measurements were obtained each night, the TAR was derived from each measurement and these values averaged over the entire measuring period (17:00 hr to 07:00 hr) for each rat. A minimum of three nights of Q.EEG measurement were chosen from those obtamed during the control, pre-nephrectomy, stage of the study, and the average TAR values were then computed over these three nights for each animal.
The animals were singly caged in clear acrylic observation chambers and their electrodes attached by light, flexible shielded cables to a digital switch box which sequentially selected the individual rat whose signal was to be measured by the EEG machine, from the group of ten connected. Selection was made by a software generated control word sent from the parallel port of a microcomputer (IBM PC/XT) which also received and processed the signal. The selected rat's EEG signal passed through the switch box to the EEG machine producing a paper record. The amplified signal was additionally sent to an analog-to-digital converter (Tecmar DT5712) where the digitized signal was read into the IBM PCIXT computer, and stored on the hard disk of the system. The system was also equipped with a digital tape backup unit (Irwin Magnetics) for permanent archiving of data. Following an EEG recording session the data were displayed on a monochrome monitor and, where required, a hard copy was produced on the attached dot-matrix printer (Epson). Data management was accomplished on a remote mainframe computer (VU VAX 8800)
accessed by modem.
Surgical
After control Q.EEG recordings had been made, all animals were surgically prepared for dialysis. The method of surgical implantation of the peritoneal dialysis catheter guide is described more fully elsewhere [23] . In use, a sterile peritoneal dialysis (PD) catheter was inserted through a chronically implanted guide to rest intraperitoneally. Through this catheter sterile dialysis fluid was instilled and withdrawn. In our preliminary studies we found that a 60 minute equilibration with therapeutic dialysate (Table 2 ) gave equilibrated peritoneal dialysate solute (EPD solute) concentrations which approximate those measured from the uremic rat's serum (Table 1) .
Such measurements, therefore, were made twice daily at 07:00 hours and 14:00 hours in lieu of blood sampling. Dialysate volumes were restricted to 20 ml to minimize solute removal from body stores. In those animals subjected to PD for control of uremia, eight exchanges (each of 30 mm dwell time) were conducted per day per rat, using 30 to 35 ml volumes (7.5% of body weight [14, 24] ). At the end of the dwell time, dialysate urea levels were 75% equilibrated with serum. Bilateral nephrectomy in those animals rendered uremic was performed using a ventral approach, with omentectomy to prevent occlusion of the PD catheter by omentum. Surgically prepared animals were then assigned to the following groups and treated according to the protocol illustrated in Figure 2 .
Treatment groups Animals of the Attrition Group (N = 10) were subjected to jugular vein catheter implantation, bilateral nephrectomy and omentectomy. These animals were not dialyzed except insofar as EPD samples were taken twice daily. The Therapeutic Dialysis Group (TD, N = 25), was treated as above except that eight exchanges of peritoneal dialysis (30 ml vol, 30 mm dwell time) were conducted using a commercial therapeutic dialysate (Table 2) between 08:00 hours and 14:00 hours each day, commencing 24 hours after nephrectomy. The Mock-Uremic Dialysis Group (M-UD, N = 10) was treated as above, except that the dialysate was formulated to contain concentrations of urea, creatinine, calcium, phosphorus, sodium, potassium, chloride, and bicarbonate similar to those found in the blood of post-48 hour nephrectomized rats (Tables 1 and 2 ). The Phosphorus Dialysis Group (P-UD, N = 8) was treated as above, except that the dialysate contained uremic (elevated) levels of phosphate, but was otherwise identical to therapeutic dialysate. The Sham Nephrectomized Group (Sham, N = 16) was omentectomized but not nephrectomized, and these renally intact rats were dialyzed as above, commencing 24 hours after nephrectomy. As illustrated in Figure 2 , daily EPD sampling, dialysis, and overnight Q.EEG measurement was continued for 70 hours.
Regional cerebral glucose uptake This was studied in animals of the Sham, Attrition and TD groups. After the morning EPD sample of the fourth day, the conscious unrestrained animals were administered a 100 tCi pulse of 14C-2-Deoxy-D-glucose via the jugular venous catheter and 45 minutes later sacrificed under light halothane anesthesia by exsanguination, perfusion and fixation (100 ml 0.9% NaCI followed by 300 ml phosphate buffered formalin, 10%, pH 7.2). Perfused brains were harvested, fixed for five further days and then microdissected for '4C-2DG estimation. The microdissection technique has been published elsewhere (Lipman and Totchard, Life Science, in press).
Briefly, this was accomplished by placing the fixed brain ventral side uppermost in a stainless steel template (Activational Systems, Inc.) and slicing coronally at 1.0 mm intervals.
The tissue slices were laid on a rubber cutting mat and 25 regions of interest extirpated by appropriately sized tissue punches using the method of Palkovits and Brownstein, and Paxinos and Watson [25, 26] . The wet tissue samples were weighed, placed in polyethylene cryovials and vacuum desiccated over calcium carbonate for 36 hours. Dry weights were then obtained and the tissue transferred to glass scintillation vials for digestion under controlled rehydration (0.5 ml Protosol, New England Nuclear, Boston, Massachusetts, USA; with 0.05 ml distilled water) in an orbital shaker for 18 hours.
Scintillation fluid (10 ml, Econoflor, DuPont, Wilmington, Delaware, USA) was then added, the vials vortexed and scintillation counting conducted for five minutes with a wide open window.
Calculation of regional cerebral glucose uptake (rCGlu) This was achieved by computing the entire '4C DPM/mg (wet weight) contained by the brain as a whole and expressing each sample DPM/mg as a fractional percentage of the whole brain total [27, 28] . This value is thus relative and dimensionless and expresses the fractional accumulation of tracer in each region of interest. This technique adjusts for the large variations in the amount of tracer found in the brains of the different animals and also many of the problems of quantitation characteristic of autoradiographic videodensitometry. Moreover, it has been validated against the latter technique by Meibach et al [27] . Values of rCGlu were computed for each sample within each brain, and the mean value obtained for each treatment to assess the effect of each treatment relative to that of the Sham group. Relative rCGlu (RrCGIu) values were calculated expressing each rCGlu value as a percentage of the parallel Sham treatment for each region of interest.
Statistics
Analysis of variance was conducted on group comparisons, pairwise analysis being made by Student's t-test. Linear regression analysis was performed by the least squares method.
Results
Control of ECF solutes by PD ECF solutes sampled by the method of low-volume (20 ml) equilibrated peritoneal dialysis (EPD) were obtained before (AM) and following (PM) the daily dialysis period on each of the two days in which PD was conducted in this study, and again on the morning of the third day before sacrifice, during rCGlu estimation. Our data are shown in Figure 3 . In undialyzed attrition animals, elevated EPD levels of urea nitrogen (134 4.8 mg/dl), creatinine (2.5 0.9 mg/dl), phosphorus (13.6 4 mg/dl), calcium (5.9
1.7 mg/dl) and potassium (6.4 Preliminary studies showed that within the twenty Hertz frequency spectrum available to our analysis, the delta range (0 to 3 Hz) was highly susceptible to breathing artifacts. The majority of the Q.EEG power, estimated from the compressed spectral array of the fast Fourier transformation resides in the rat as in man, within the ten Hertz range encompassed by theta (3 to 7 H) and alpha (7 to 13 Hz) frequency bands which are the components of our index, the theta:alpha ratio (TAR).
The control value (mean sEM) of the TAR was thus calculated to be 1.57 0.29 for the entire group of rats, the standard error being 18% of the mean. This variation is compounded of both inter-and intra-animal variation and includes a component, therefore, from each animal's circadian and infradian rhythms over the measuring period (14 hours from each of three days). Nephrectomy unrelieved by dialysis (attrition treatment) was temporally associated with a linear increase in the TAR (P < 0.05 compared with control value). Therapeutic dialysis of nephrectomized animals significantly (P <0.001) reduced TAR values below those in the attrition animals to levels comparable (P > 0.05) to those of the sham nephrectomized animals.
Dialysis of nephrectomized animals using either M-UD or P-UD solutions (Table 2 ) produced comparable (P > 0.05) levels of TAR that were intermediate between those of the attrition and the TD treated animals (P < 0.05).
Relationship between Q.EEG and EPD-solutes
Overnight average concentrations (PM to AM) were calculated for each of the measured solutes so as to obtain a single value representative of each solute's concentration during the period of Q.EEG measurement. Linear least squares regression analysis was then conducted between each animal's overnight average TAR value and its overnight average chemistry values. Small positive correlations were found for urea nitrogen (r = 0.37, P < 0.001); creatinine (r = 0.31, P < 0.01); and phosphorus (r = 0.31, P < 0.01). The correlation between TAR and overnight average calcium concentration (r = 0.184) was not statistically significant (P = 0.09). These correlations were comparable with values obtained in our earlier work [19] . In the Sham animals, a small positive correlation was found between TAR and urea nitrogen but otherwise no relationship was found. TD animals resembled Sham animals in that the positive correlations associated with the attrition state were not evident. Correlations between TAR and overnight average EPD solute levels was largely negative in the M-UD and P-UD groups.
Regional cerebral glucose uptake studies At the time of measurement, relative regional cerebral glucose uptake (RrCG1u) values of the animals of the attrition group differed (P < 0.05) from those of the Sham group at only three brain sites: hippocampus, geniculate nuclei and the sub- flecting the relatively high level of dialysate calcium and possibly increased parathyroid hormone secretion. M-UD treatment generally maintained the EPD solute burden at high levels, stantia nigra (Fig. 6) . The effect of TD treatment on glucose sometimes higher than dialysate levels, presumably due to incorporation in these areas is illustrated in Figure 7 . At the continued solute generation. However, the decrease in PM geniculate bodies the depressed RrCG1u associated with unre-values on day 2 in spite of the M-UD treatment suggests that lieved nephrectomy was attenuated by a prior history of TD (P endogenous solute generation had slowed, perhaps reflecting <0.05 compared with Sham); but similarly improved values at decreased solute ingestion (not measured) due to uremic anothe hippocampus and substantia nigra did not reach statistical rexia. As anticipated and intended, P-UD treated nephrectosignificance.
mized animals displayed an EPD solute profile comparable to TD treated rats with the exception of EPD-phosphate levels Discussion which were comparable to those of both M-UD and attrition Control of EPD solute concentrations groups (P > 0.05). Abnormal ECF solute burdens accumulate rapidly and inexorably in the totally nephrectomized rat. From Figure 3 it can Association of EPD solutes and Q.EEG be seen that the major extent of solute elevation was achieved When the removal of ingredient solutes was prevented by M-UD treatment, we nevertheless observed a partial amelioration of the increased TAR due to nephrectomy (Fig. 5) . However, the encephalopathy was also not exacerbated. Clearly therefore, some neurotoxic component of the uremic ECF was removed or (alternatively) an indirect adaptive injury was ameliorated by M-UD treatment; this component was not one of the commonly measured solutes with which the M-UD solution had been formulated. We therefore infer: (1) the presence of some other, unmeasured, dialysable neurotoxic substance that is removed (altered) during M-UD dialysis and that produces the slowing effect on the Q.EEG; and (2) that one or more of the M-UD component solutes continues or synergizes with the action of this unknown uremic neurotoxin since the TAR response is incomplete when compared with the effect of TD. Since TD treatment itself reduced elevated TAR values to within the Sham group range, we would suggest that the effect of TD treatment is to reduce the levels of this hypothetical neurotoxin to subtoxic concentrations within our bioassay.
Presumably M-UD treatment was equally efficacious in this regard, yet dialysis with M-UD solutes failed to completely suppress the neurotoxic effects. Since only weak correlations were found between TAR and EPD solutes in the M-UD group, this tends to rule out any direct dose-dependent role for any of these solutes in the neurotoxic effect. On the other hand, increasing levels of the (unknown) neurotoxin could account for the increasing TAR as these EPD levels fell overnight during the time of Q.EEG measurement, probably due to reduced generation of the ingredient solute. It seems plausible to conclude that some component of the M-UD solution interacted with a residual neurotoxic effect to prevent the full ameliorative effect of dialysis (TD) on the Q.EEG. Our findings obtained with the P-UD treatment (Fig. 5) suggest that this component may be phosphorus, or phosphorus-induced. Phosphorus may exert indirect neurotoxic effects via an action on parathyroid hormone. Elevated phosphorus levels are known to stimulate the parathyroid glands to increase PTH production. In an anephric animal such as the present model, the normal negative feedback effect of PTH on phosphorus excretion-stimulation-cannot operate, leading presumably to enhanced PTH levels and further enhancement of its neurotoxicity. Arieff and Massry [54] and also Cooper, Lazarowitz and Arieff [55] have reported-in support of this hypothesis-that abnormal EEG patterns associated with the slowing of the EEG frequencies are correlated with PTH elevation. PTH neurotoxicity may arise from its ability to depress neuronal conduction velocity, an effect most probably engendered via deranged calcium metabolism and increased calcium burden within the nerve, according to the work of Mahoney and Arieff [56] . Goldstein, Chui and Massry [571 have shown that a parathyroid extract reversibly increases the calcium burden of dog nerve. They find, moreover, that depression of conduction velocity is in correlation with the nerve calcium burden.
Solutes other than phosphorus remain to be tested in our assay by means of solute-specific dialysis. Moreover, because generation and retention of other unmeasured solutes presumably proceeded concurrently with those we measured, we are unable to conclude that the measured solutes themselves engendered the associated TAR increases.
The technical and analytic loads of these initial experiments precluded control or examination of such further important variables as nutritional intake (such as, by pair-feeding the animals), dialysate protein loss, nitrogen balance, or the responses of parathyroid or other hormone secretion rates and levels.
ECF solutes, the Q.EEG and brain glucose uptake Having documented the production by nephrectomy and remission by peritoneal dialysis of uremic encephalopathy in a laboratory model employing conscious ambulatory rats, we next began an initial exploration of possible cerebral mechanisms for these effects. Since glucose is the brain's primary energy source, we hypothesized that glucose metabolism, and perhaps uptake might be altered in this model. Hence measure- C.!, 0 brain, methods for direct counting of microdissected brain tissue were chosen [27, 28] . This choice also circumvented problems in the usual techniques of quantifying autoradiographically detected tracer [48] . Precedents for these methods for localization of cerebral metabolic responses to functional activity are known in such applications as olfactory stimulation [461, peripheral nerve stimulation or visual deprivation [47] , effects of lysine vasopressin and ACTH fragments [49] , the ACTH analogs, alpha-MSH and corticosterone [48] and Naloxone [501.
The neurotoxic effects of aluminum salts have recently been quantified by this technique (Lipman and Tolchard, Life Science, in press). Accordingly 20 brain areas were surveyed and the counts in each were factored by the whole brain uptake in each animal, then aggregated, to permit comparison of the regional cerebral glucose uptake (rCGlu) in attrition and Sham groups (Fig. 6 ). While we expected rCGlu deficits in cortical sites and in the thalamic nuclei of origin of the thalamocortical (corticofugal) rhythm generators, no such deficits were found. The neurophysiological source of Q.EEG slowing in this model has thus not been identified, either because the slowed electrical activity does not depend upon reduced glucose uptake, or because the method is too insensitive to detect the small magnitude of changes in these and other brain areas. Instead, as illustrated in Figure 6 , rCGlu was reduced only in the geniculate, substantia nigra and hippocampal areas. When the changes are expressed as relative regional cerebral glucose uptake (RrCG1u) as a percent of the Sham group value (Fig. 7) , the depressive effect of untreated uremia is again seen in the attrition group. Presumably as a result of prior therapeutic dialysis, glucose uptake in the TD group does not differ statistically from that in the Sham animals, but improvement from attrition levels reaches statistical significance only in the geniculate area. The mechanistic basis for these effects remains to be explored.
These three areas may, however, be functionally relevant to certain functional cerebral deficits in renal failure if not to the Q.EEG slowing. For example, the 'geniculate' tissue sampled in these studies mainly comprised the lateral geniculate nuclei which are the primary neural relays to the visual cortex [52] . A similar metabolic deficit in this area in man may be the biological basis for the deficits in the visual evoked potential latencies observed in human renal failure [34] [35] [36] 511 . The substantia nigra, containing the dopaminergic nuclei of the extrapyramidal nigrostriatal tract, is involved in initiation of movement and fine motor control. Deficits here may be responsible for the reduced locomotor activity as well as the tremors typical of uremic encephalopathy in the rat as in man and other species. Finally, the hippocampus is involved in learning and memory, both of which are deficient in encephalopathic uremic patients and in animal models of the condition [39] [40] [41] [42] 53 ].
In conclusion, the present model provides a bioassay with which to investigate the effects and identity of the "uremic neurotoxin(s)" and may find utility in investigations of neuropharmacological effects in the altered uremic state. Our present data suggest that the "unknown dialysable neurotoxin" is peritoneally permeable in this model (that is, has a molecular weight of <15000) and is not identical with any of the commonly measured solutes. Its toxicity is enhanced, however, by uremic levels of one or more of these solutes for which role phosphorus is provisionally a likely candidate.
